JP Morgan Chase’s Select Medical SEM Stock Holding History
Bought
Maintained
Sold
Other funds holding SEM
VPM
VCM
GCL
JP Morgan Chase's SEM Position: Q1 2026 in Review
JP Morgan Chase increased its Select Medical (SEM) stake by 31% in Q1 2026, buying an estimated $1.08M and bringing the position to 290,638 shares worth $4.73M. The position accounts for ﹤0.01% of the portfolio, ranked #3363.
JP Morgan Chase first reported a position in SEM in Q2 2013 and has held it in 51 quarters since. The position peaked at $25.2M in Q1 2021. 277 funds tracked by Wall St. Rank hold SEM as of Q1 2026.
- JP Morgan Chase held 290,638 shares of Select Medical worth $4.73M as of Q1 2026.
- JP Morgan Chase bought 69,068 Select Medical shares in Q1 2026, an estimated $1.08M.
- Select Medical made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #3363 holding.
- JP Morgan Chase first reported a position in Select Medical in Q2 2013 and has held it in 51 quarters since.
- JP Morgan Chase's Select Medical position peaked at $25.2M in Q1 2021.
- 277 funds tracked by Wall St. Rank held Select Medical as of Q1 2026.
Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.